Trial Profile
A Phase 1, Open- Label Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Methotrexate
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Mar 2017
Price :
$35
*
At a glance
- Drugs Isavuconazonium (Primary) ; Methotrexate
- Indications Aspergillosis; Candidiasis; Haematological malignancies; Invasive bronchopulmonary aspergillosis; Mycoses; Zygomycosis
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 25 May 2015 New trial record